Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality, however with no effective therapy available. Methods: The effect of favipiravir (FPV) in treating SFTS was evaluated by an integrated analysis on data collected from a single-arm stu...
Main Authors: | Yang Yuan, Qing-Bin Lu, Wen-Si Yao, Jing Zhao, Xiao-Ai Zhang, Ning Cui, Chun Yuan, Tong Yang, Xue-Fang Peng, Shou-Ming Lv, Jia-Chen Li, Ya-Bin Song, Dong-Na Zhang, Li-Qun Fang, Hong-Quan Wang, Hao Li, Wei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421003844 |
Similar Items
-
Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection
by: Mutsuyo Takayama-Ito, et al.
Published: (2020-02-01) -
Effective Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus in an in vitro Model
by: Mi-Seon Bang, et al.
Published: (2022-03-01) -
Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
by: Hideki Tani, et al.
Published: (2016-02-01) -
Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
by: Hiroyuki Takoi, et al.
Published: (2020-12-01) -
Hedgehogs as Amplifying Hosts of Severe Fever with Thrombocytopenia Syndrome Virus, China
by: Chaoyue Zhao, et al.
Published: (2022-12-01)